top of page


CEBINA uniquely supports life science entrepreneurs and early-stage start-up companies and develops cutting-edge biotech projects



CEBINA was founded to create, nurture, and promote early-stage life sciences companies,

to develop new medicines and cutting-edge technologies.


With decades-long experience in pharmaceutical product development and biotech entrepreneurship, our team supports our internal projects and resident companies with cutting-edge facilities and tailor-made services throughout all stages of company development.


For each new project, CEBINA undertakes extensive due diligence to identify projects with the highest potential, offering attractive, de-risked opportunities for investors.

DN Logo square.png

28 February 2024

CEBINA announces the launch of DanubeNeuro, an acceleration program transforming insightful neuroscience research into novel therapeutics

Read more


18 December 2023

Eveliqure initiates clinical safety and immunogenicity trials of its vaccine candidate against Shigellosis and ETEC in endemic populations in Bangladesh

Read more

DL square for CEBINA website.png

12 September 2023

Danube Labs: Call for Proposals - September 2023

Read more


Karl-Farkas-Gasse 22

1030 Vienna, Austria

bottom of page